Spyglass Ophthalmics, Inc. – Trademark Portfolio
Entity Type: 03
Spyglass Ophthalmics, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SPYGLASS PHARMA and SPYGLASS OPHTHALMICS. The owner is based in Laguna Niguel, CA.
28602 Rancho Grande
Laguna Niguel, CA 92677
Showing of trademarks Trademarks
Trademark Classifications
Spyglass Ophthalmics, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Spyglass Ophthalmics, Inc. have?
Spyglass Ophthalmics, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 abandoned.
What trademark classes does Spyglass Ophthalmics, Inc. file in?
Spyglass Ophthalmics, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Spyglass Ophthalmics, Inc.'s most well-known trademarks?
Spyglass Ophthalmics, Inc.'s registered trademark portfolio includes well-known marks such as SPYGLASS PHARMA and SPYGLASS OPHTHALMICS. These are among 2 currently registered trademarks in the portfolio.
What is Spyglass Ophthalmics, Inc.'s trademark registration success rate?
Spyglass Ophthalmics, Inc. has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.